Hyperinsulinemia in nonobese women reporting a moderate weight gain at the beginning of menopause: A useful early measure of susceptibility to insulin resistance

Menopause

Volumn 17, Issue 2, 2010, Pages 321-325

  Lemay, André ^a,b   Turcot, Lucile ^a   Déchêne, Francine ^a   Dodin, Sylvie ^a,b   Forest, Jean Claude ^b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Body circumferences; Highdensity lipoprotein cholesterol; Insulin resistance; Menopause; Triglycerides; Weight gain

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ABDOMEN; ADULT; AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; EATING HABIT; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HIP; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; HYSTERECTOMY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; POSTMENOPAUSE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT GAIN;

ANTHROPOMETRY; BLOOD GLUCOSE; BODY COMPOSITION; DISEASE SUSCEPTIBILITY; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; LIPIDS; MENOPAUSE; MIDDLE AGED; PREVALENCE; WEIGHT GAIN;

EID: 77949384533     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181b7c521     Document Type: Article

References (26)

1. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995;123:673-675.
2. Hoover LW, Boote EJ. Longitudinal assessment of intra-abdominal fat in postmenopausal women. Ann N Y Acad Sci 2000;904:520-525.
3. Tremollieres FA, Pouilles JM, Ribot CA. Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol 1996;175:1594-1600.
4. Tchernof A, Poehlman ET. Effects of the menopause transition on body fatness and body fat distribution. Obes Res 1998;6:246-254.
5. Soler JT, Folsom AR, Kaye SA, Prineas RJ. Associations of abdominal adiposity, fasting insulin, sex hormone binding globulin, and estrone with lipids and lipoproteins in post-menopausal women. Atherosclerosis 1989;79:21-27.
6. Ostlund RE Jr, Staten M, Kohrt WM, Schultz J, Malley M. The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults. N Engl J Med 1990;322:229-234.
7. Callaway C. Circumferences. In: Lohman T, ed. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics Books, 1988:39-46.
8. Moisan J, Meyer F, Gingras S. A nested case-control study of the correlates of early menarche. Am J Epidemiol 1990;132:953-961.
9. Gionet NJ, Godin G. Self-reported exercise behavior of employees: a validity study. J Occup Med 1989;31:969-973.
10. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985;10:141-146.
11. Lemay A, Dodin S, Kadri N, Jacques H, Forest JC. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterole-mic menopausal women. Obstet Gynecol 2002;100:495-504.
12. Lemay A, Dodin S, Turcot L, Dechene F, Forest JC. Estrogen/ progesterone replacement versus pravastatin and their sequential association in hypercholesterolemic postmenopausal women. Maturitas 2001;40:247-257.
13. Lemay A, Dodin S, Cedrin I, T-Lemay L. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during trans-dermal oestradiol sequentially combined with oral medroxyprogesterone acetate. Clin Endocrinol (Oxf) 1995;42:341-351.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and A-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
15. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2192.
16. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
18. Health Canada. Canadian Guidelines for Body Weight Classification in Adults, 2003. Ottawa, Canda: Health Canada.
19. Lee CM, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol 2008;61:646-653.
20. Schneider HJ, Glaesmer H, Klotsche J, et al. Accuracy of anthropo-metric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab 2007;92:589-594.
21. Committee Canadian Diabetes Association Clinical Practice Guidelines Expert. Screening for type 1 and type 2 diabetes. Can J Diabetes 2008; 32:S14-S16.
22. Piche ME, Lemieux S, Perusse L, Weisnagel SJ. High normal 2-hour plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes. Diabetologia 2005;48: 732-740.
23. Blanchet C, Dodin S, Dumont M, et al. Bone mineral density in French Canadian women. Osteoporos Int 1998;8:268-273.
24. Blanchet C, Giguere Y, Prud'homme D, et al. Leisure physical activity is associated with quantitative ultrasound measurements independently of bone mineral density in postmenopausal women. Calcif Tissue Int 2003;73:339-349.
25. Kongnyuy EJ, Norman R, Flight IH, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database Syst Rev 2005;3:CD001018.
26. Gaspard U. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women. Maturitas 2009;62:362-365.